Luxeptinib
Luxeptinib (CG-806) is an orally available, non-covalent pan-FLT3/BTK inhibitor. It demonstrates potent reversible inhibition, inducing cell death in AML models through apoptosis, autophagy, and cell cycle arrest in preclinical studies.
Product Specifications
CAS Number
1616428-23-9
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Smiles
Cc1c[nH]c (n1) -c1ccc (c2CNC (=O) c12) -c1ccc (NC (=O) Nc2c (F) cc (F) cc2F) cc1F
Molecular Formula
C25H17F4N5O2
Molecular Weight
495.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6468847-01 0.1 mL
Cholinergic receptor, nicotinic, beta 2 (CHRNB2, Acrb2, N-alpha 1, Neuronal acetylcholine receptor non-alpha-1 chain, Neuronal acetylcholine receptor subunit beta-2) (MaxLight 405)
Sign In for Pricing
View Details MBS6468847-02 5x 0.1 mL
Cholinergic receptor, nicotinic, beta 2 (CHRNB2, Acrb2, N-alpha 1, Neuronal acetylcholine receptor non-alpha-1 chain, Neuronal acetylcholine receptor subunit beta-2) (MaxLight 405)
Sign In for Pricing
View Details 
GTR15093279 1 Vial
Lentiviral human CPLX4 shRNA (UAS) - Lentiviral human CPLX4 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details TA332607 100 µL
Plasma Kallikrein 1B (KLKB1) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details